Welcome to the Capsugel Newsroom where we feature the latest information on our offerings, technology and capabilities. Our Capsugel In the News is a sampling of recent media coverage that demonstrates our technology and thought leadership showcasing our products, services and subject matter experts.
Filter Results By:
Lonza Adds Color to the Clean-Label Experience
Nov 07, 2018
view news
Lonza Boosts Clean-Label Offering with DRcaps™ NON-GMO Project Verification
Nov 07, 2018
view news
Lonza's Capsule Delivery Solutions Launches Capsugel® Colorista™
Aug 31, 2018
Colorista™ capsules contain a broad selection of colorants suitable for use in major markets, allowing pharmaceutical customers to have access to a wide array of colors, and are available in both Vcaps® Plus (HPMC) and Coni-Snap® gelatin.
view news
Lonza's Capsule Delivery Solutions Launches Capsugel® Vcaps® Gen C, a New Specialty Polymer Capsule
Jun 19, 2018
Continuing to pioneer specialty polymer capsules, the Capsugel® HPMC portfolio gets enriched with Vcaps® Gen C Capsules, advancing the ability of pharmaceutical manufacturers to qualify a high-performing gelling agent-based capsule, with the Capsugel® high quality and performance standards.
view news
Lonza Consumer Health and Nutrition to Present Cutting-Edge Delivery Solutions for Science-Backed Ingredients at Vitafoods Europe 2018
Apr 18, 2018
Vitafoods Europe is the annual event where the global nutraceutical supply chain comes together to do business. The event takes place in Geneva, Switzerland, on May 15-17. Visit our booth # G10 to learn more.
view news
Lonza Consumer Health and Nutrition to Highlight Innovative Clean Label Solutions at Natural Products Expo West 2018
Mar 09, 2018
view news
Study Further Positions Lonza's UC-II® Undenatured Type II Collagen as a Leader in the Crowded Joint-Health Market
Feb 16, 2018
view news
Serialization Capabilities Now Operational at Lonza Edinburgh Facility for Liquid-Filled Hard Capsules
Dec 15, 2017
Basel, Switzerland, 14 December 2017 – Lonza announced today that its integrated development and manufacturing site for biopharmaceutical liquid-filled hard capsules in Edinburgh (UK) has new anti-counterfeiting security capabilities in place and is in full compliance with EU and U.S. regulatory requirements for serialization. Lonza’s customers will benefit from this investment to secure the integrity of sales packs now and in the future.
view news
Capsugel Announces Expanded Capabilities for Clinical Trial Services and High-Potency Compounds at Edinburgh Facility
Oct 31, 2017
view news
Lonza Completes Acquisition of Capsugel to Create Leading Integrated Solutions Provider to the Global Pharma and Consumer Healthcare Industries
Jul 06, 2017
view news
Are you a member of the media looking to learn more about Capsugel?
contact us
Thanks for
contacting Capsugel

A representative will be in touch. Want to have access to the latest news, whitepapers, webinars and Knowledge Center Content? Create an account with Capsugel!

Already have an account? Log In To Get Full Access

Create Account